Replies to post #3163 on The Rising Influence of Rising Affluence

[DewDiligence]

Is ABT more exposed to emerging markets than most other large pharmas?

Yes, it is. As a result of recent acquisitions, ABT is the largest drug company in India—see #msg-50436738, #msg-50022514, and #msg-62037218 for related info.

[DewDiligence]

ABT’s 2Q11 sales in emerging markets:



http://finance.yahoo.com/news/Abbott-Reports-11-Percent-prnews-3161741589.html?x=0&.v=1

Note: The year-over-year growth rates are somewhat inflated because the Piramal acquisition announced in in May 2010 (#msg-50436738) did not close until in Sep 2010 and hence was not in the 2Q10 base number for calculating 2Q11 YoY growth.